MG Composite Score — NerveSync Neurology

Patient Name

Date of Birth

Assessment Date

Total Score

0/50

Severity

Minimal

Prior Visit

Change: — MCID = 3 points

Item weights vary: bulbar and respiratory items carry up to 9 points; ocular items max 2–3. This reflects the relative clinical impact of each domain.
Physician items: Ptosis, diplopia, eye closure, and limb strength items are clinician-examined.
Patient-reported items: Talking, chewing, swallowing, and breathing are based on patient report (over the preceding week).
Neck: Score the weaker of flexion or extension.
MCID: A 3-point improvement is the threshold for clinically meaningful response, used in REGAIN, ADAPT, and MycarinG trials.
Pairs well with: MG-ADL (patient-reported, 0–24) and QMG (quantitative myasthenia gravis test) for trial-level granularity.

Burns TM, Conaway M, Sanders DB. The MG Composite: A valid and reliable outcome measure for myasthenia gravis. Neurology 2010;74(18):1434–1440.